ERBB2 and breast carcinoma: Indeed, Koh et al. thoroughly evaluated the association between PLR and mortality by breast cancer subtype and demonstrated that elevated PLR was associated with an increased risk of mortality in patients with ER+ or PR+ and HER2+ breast cancer but not in patients with ER− or PR− and HER2+ breast cancer [15].